A system to treat Heart Failure with preserved Ejection Fraction (HFpEF)
Pumpinheart, a Royal College of Surgeons in Ireland (RCSI) spinout company, is developing a device to treat HFpEF.
A DEVICE TO TREAT HFPEF
_Still.jpg/:/cr=t:16.67%25,l:0%25,w:100%25,h:66.67%25/rs=w:365,h:182.5,cg:true)
The PReduction device to treat HFpEF
The PReduction device to treat HFpEF
The PReduction device to treat HFpEF
The PReduction device (patent pending) is an ECG gated implantable diastolic pump in the left ventricle that reduces left atrial pressure during diastole and in sympathy with elevated pressures during exercise.
A transcatheter implantable pump
The PReduction device to treat HFpEF
The PReduction device to treat HFpEF
The sub-dermal power and control unit is connected to pressure sensors, an ECG sensor and the PReduction device in the left ventricle via a driveline in the left subclavian vein.
Transcutaneous Energy Transfer System
Transcutaneous Energy Transfer System
Transcutaneous Energy Transfer System
The PReduction device (patent pending) is powered and controlled by a Transcutaneous Energy Transfer System (TETS) and subdermal unit located below the left clavicle with the driveline wire delivered via catheter.
A cath lab procedure
Transcutaneous Energy Transfer System
Transcutaneous Energy Transfer System
The PReduction Device (patent pending) is delivered via transcatheter implantation via femoral venous access in a cath lab by an interventional cardiologist.
WHAT OUR DEVICE DOES
For Heart Failure Clinicians
For Heart Failure Clinicians
For Heart Failure Clinicians
The PReduction device aims to treat Stage C and D (NYHA classification) HFpEF ambulatory patients and enable HFpEF patients to survive HFpEF and live active lives at home.
For Hospital Management
For Heart Failure Clinicians
For Heart Failure Clinicians
The PReduction device is designed to be delivered in a cath lab with associated accessibility and short post operative recovery. The device promises to reduce HFpEF hospitalisations and the associated burden of cost on healthcare systems.
For HFpEF Patients
For Heart Failure Clinicians
For HFpEF Patients
The PReduction device is at pre-clinical research phase and at least seven years years of further research and clinical trials are required before it shall be approved, certified and available.
PARTNERS
AWARDS and GRANTS
National Startup Awards 2022 Medtech Startup Silver Winner
Government of Ireland Disruptive Technologies Innovation Fund (DTIF) Award
Government of Ireland Disruptive Technologies Innovation Fund (DTIF) Award
Pumpinheart won Silver Award in National Startup Awards 2022 (Ireland) in the Medtech Startup category.
Government of Ireland Disruptive Technologies Innovation Fund (DTIF) Award
Government of Ireland Disruptive Technologies Innovation Fund (DTIF) Award
Government of Ireland Disruptive Technologies Innovation Fund (DTIF) Award
€3.14M awarded under DTIF Call 4 (2021 – 2022) to Pumpinheart-led consortium comprising Pumpinheart, Boston Scientific, Gentian Health and the Royal College of Surgeons in Ireland to support preclinical development of the PReduction Device to treat HFpEF.
TERMIS-AM 2022 Business Plan Competition
Government of Ireland Disruptive Technologies Innovation Fund (DTIF) Award
Enterprise Ireland Commercialization Fund Grant
Winner: Pumpinheart.
12th July 2022
Enterprise Ireland Commercialization Fund Grant
European Society for Clinical Investigation (ESCI) Award
Enterprise Ireland Commercialization Fund Grant
€500k awarded to RCSI to research and develop PReduction - a novel device for HFpEF (2019).
European Society for Clinical Investigation (ESCI) Award
European Society for Clinical Investigation (ESCI) Award
European Society for Clinical Investigation (ESCI) Award
€10k awarded to to Dr Aamir Hameed RCSI for Exploratory Research (2020).
EVENTS
Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference
Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference
Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference
The Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference event begins with a Reception and Dinner at the Sharon Heights Golf & Country Club, Menlo Park, California on Thursday, June 15, followed by the WSGR MDC conference on Friday, June 16, at the Palace Hotel, San Francisco.
MedTech Innovator Accelerator 2023 Cohort Innovator Summit
Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference
Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference
The MedTech Innovator Accelerator 2023 Cohort program launches June 14-15, at the Innovator Summit at The Computer Museum, in Mountain View, California.
MedTech Innovator Dublin 2023 pitch event
Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference
MedTech Innovator Dublin 2023 pitch event
Pumpinheart advances to pitch at the MedTech Innovator event on 24th April in Dublin as part of the selection process in the MedTech Innovator 2023 Road Tour. The pitch event is co-located with MedTech Strategist conference 25th-27th April at The Shelbourne Hotel.
Enterprise Ireland Start-Up Showcase 2023
Wilson Sonsini (WSGR) MDC 2023 Medical Device Digital Health Conference
MedTech Innovator Dublin 2023 pitch event
Pumpinheart is attending the Enterprise Ireland Start-Up Showcase on the 18th April 2023 in the Main Hall RDS Dublin.
Medtech Connect Showcase
Enterprise Ireland Big Ideas Event
Enterprise Ireland Big Ideas Event
Pumpinheart selected as one of five finalists to pitch at Medtech Rising’s new “MedTech Connect” Showcase", in the Galmont Hotel, Lough Atalia Road, Galway at on Thursday 1st December 2022.
Enterprise Ireland Big Ideas Event
Enterprise Ireland Big Ideas Event
Enterprise Ireland Big Ideas Event
Pumpinheart presented as one of a dozen investor-ready startups at the Enterprise Ireland Big Ideas event at Hogan Suite Croke Park Thursday 24th November 2022